AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inmune Bio, Inc. Director's Dealing 2019

May 9, 2019

34518_dirs_2019-05-09_c7c13319-0677-4391-99ab-96a6dba27d6f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Inmune Bio, Inc. (INMB)
CIK: 0001711754
Period of Report: 2019-05-02-06:00

Reporting Person: Tesi Raymond Joseph (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-02-06:00	Common Stock	P	11100	$9	Acquired	1526933	Direct

Footnotes

F1: Includes 11,100 shares of the Issuer's common stock acquired by the Reporting Person in connection with a private placement effected as of May 2, 2019.

This amendment was filed to correct the purchase price of the securities acquired by the Reporting Person.